CD4 and neoplasm: Importantly, DCs phagocytose apoptotic tumor cells, process tumor antigens, present them via MHC‐I and MHC‐II molecules, migrate to regional lymph nodes, and activate naive CD4+ and CD8+ T cells to initiate an antitumor immune response [138].